Nasdaq auph
According to NASDAQ, as of May 2014, the highest NASDAQ closing ever was achieved on March 9, 2000, when the market closed at a record 5046.86. USA Today reports that the highest closing achieved by NASDAQ since was a 4007.09 closing on Nov...Home AUPH • NASDAQ Aurinia Pharmaceuticals Inc Follow Share $9.06 After Hours: $9.03 (0.33%) -0.030 Closed: Dec 1, 7:57:38 PM GMT-5 · USD · NASDAQ · Disclaimer search …
Did you know?
Aurinia Pharmaceuticals (NASDAQ:AUPH) is a company that specializes in developing treatments for diseases that currently have few treatment options. They focus on autoimmune, kidney, and rare ...Jul 18, 2023 · Aurinia Pharmaceuticals ( NASDAQ: AUPH) is a biopharmaceutical firm delivering therapies for autoimmune, kidney, and rare diseases with unmet medical needs. In 2021, it introduced Lupkynis ... Nov. 20, 2023, 12:38 PM. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are trading higher, adding to gains of more than 17% over the last week. The stock has been trending higher since the ...The largest shareholder of Aurinia Pharmaceuticals ( NASDAQ: AUPH) said it plans to withholder support for seven board members at the company's upcoming annual meeting. Iljin SNT, which has a 6.1% ...The average twelve-month price prediction for Aurinia Pharmaceuticals is $14.00 with a high price target of $15.00 and a low price target of $13.00. Learn more on AUPH's analyst rating history. Do Wall Street analysts like Aurinia Pharmaceuticals more than its competitors?EDMONTON, Alberta--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (“Aurinia” or the “Company”) today announced that its Board of Directors (“the Board”) has appointed Dr ...Anyone who held Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) over the last year knows what a loser feels like. The share price has slid 66% in that time. On the bright side, the stock is actually up 50%Dec 4, 2023 · Shares of NASDAQ AUPH opened at $9.06 on Monday. The company has a current ratio of 5.77, a quick ratio of 5.33 and a debt-to-equity ratio of 0.18. Aurinia Pharmaceuticals Inc. has a twelve month low of $4.07 and a twelve month high of $12.43. The stock has a 50 day moving average of $7.93 and a two-hundred day moving average of $9.20. Nov 20, 2023 · Nov. 20, 2023, 12:38 PM. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are trading higher, adding to gains of more than 17% over the last week. The stock has been trending higher since the ... Based on analysts offering 12 month price targets for AUPH in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that...The public float for AUPH is 130.54M, and currently, shorts hold a 13.23% of that float. The average trading volume for AUPH on November 16, 2023 was 1.69M shares. AUPH) stock’s latest price update. The stock price of Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has dropped by -0.12 compared to previous close of 8.17.Aurinia Pharmaceuticals AUPH shares ended the last trading session 5.7% higher at $9.68. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...Dec 4, 2023 · December 4, 2023. Business. B. Riley Financial Inc (NASDAQ:RILY) has a beta value of 1.57 and has seen 0.91 million shares traded in the recent trading session. The company, currently valued at $723.52M, closed the recent trade at $23.66 per share which meant it gained $3.51 on the day or 17.42% during that session. NEW YORK, May 29, 2022 (GLOBE NEWSWIRE) -- BrAurinia Pharmaceuticals Price Performance Share Swiss National Bank raised its holdings in shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 7.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).The firm owned 279,300 shares of the biotechnology company’s stock after acquiring an …NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that... Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading hi Based on analysts offering 12 month price targets for AUPH in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . As of March 2015, Theranos is a private company and does
December 4, 2023. Company. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has a beta value of 1.39 and has seen 0.72 million shares traded in the recent trading session. The company, currently valued at $1.27B, closed the recent trade at $8.82 per share which meant it lost -$0.24 on the day or -2.60% during that session.Aurinia Pharmaceuticals (NASDAQ:AUPH) and Disc Medicine (NASDAQ:IRON) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, community ranking, institutional ownership, media sentiment, dividends, risk, analyst …Gainers iSpecimen Inc. (NASDAQ:ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced ...AUPH: Get the latest Aurinia Pharmaceuticals stock price and detailed information including AUPH news, historical charts and realtime prices. Indices Commodities Currencies Stocks
Aurinia Pharmaceuticals Price Performance Shares of NASDAQ AUPH opened at $9.06 on Monday. The company has a current ratio of 5.77, a quick ratio of …Noteworthy Friday Option Activity: W, ON, AUPH. July 28, 2023 — 04:50 pm EDT. Written by BNK Invest for BNK Invest ->. Looking at options trading activity among components of the Russell 3000 ...The FDA is scheduled to rule on Aurinia Pharmaceuticals Inc's (NASDAQ:AUPH) voclosporin as a treatment option for lupus nephritis. SHARE THIS POST. FACEBOOK. TWITTER. EMAIL. COPY LINK.…
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Aurinia Pharma (NASDAQ:AUPH) is schedule. Possible cause: Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2023 Earnings Call Transcript November.
This page of Aurinia Pharmaceuticals (AUPH) displays a brief signal update and a market outlook, as well as a candlestick chart showing the last detected ...Jan 5, 2023 · Aurinia Pharmaceuticals (NASDAQ:AUPH) recently announced they have reached a settlement with Sun Pharmaceuticals (OTCPK:SMPQY) to dismiss their claims and counterclaims against each other.
Market Capitalization. $1.24 billion. P/E Ratio. N/A. Dividend Yield. N/A. Price Target. $14.00. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media.With the business potentially at an important milestone, we thought we'd take a closer look at Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) future prospects. Aurinia Pharmaceuticals Inc., a ...Earnings vs Market: AUPH is forecast to become profitable over the next 3 years, which is considered above average market growth. High Growth Earnings: AUPH …
Agios Pharmaceuticals (NASDAQ:AGIO) and Aurinia Phar Analyst's Opinion · Consensus Rating. Aurinia Pharmaceuticals has received a consensus rating of Buy. · Price Target Upside/Downside. According to analysts' ... SVB Leerink waxed optimistic on Aurinia PharmaceutiAurinia Pharma (NASDAQ:AUPH) is scheduled to announce Q3 e In a recent SEC filing, Russell Investments Group Ltd. revealed that it had added to its portfolio with a new stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSE:AUP). The biotechnology company has become an attractive option for investors due to their focus on developing and commercializing therapies for diseases with unmet …At Aurinia, we embrace the possibility to change the trajectory of autoimmune diseases with unmet needs. With a growing pipeline and a dynamic team of proven experts, our work is patient-centric and driven by a sense of urgency. See how we are poised to deliver on our mission. Learn More. Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) institutiona Aurinia Pharmaceuticals ( AUPH 1.10%), a small-cap commercial-stage drugmaker, is having another strong session today. Specifically, the biotech's stock was up by 11.9% on moderate volumes as of 1 ... The largest shareholder of Aurinia Pharmaceuticals ( NASDAQ:Aurinia Pharmaceuticals Inc Ordinary Shares (AUSAN DIEGO, April 20, 2022 (GLOBE NEWSWIRE) -- The la Principal Financial Group Inc. cut its position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 8.4% in the 2nd quarter, according to its most recent filing with the ...Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. December 4, 2023. Technologies. Vertex Energy Inc (NASDAQ Aurinia Pharmaceuticals (NASDAQ: AUPH) will report its Q2 2021 earnings after the closing bell today and investors will want to pay attention to sales and any color management provides on its ... NASDAQ:AUPH. Press Releases. May 17, 2023. Aurinia Announce[Aurinia Pharmaceuticals ( NASDAQ: AUPH) rose 5% in regular trading AUPH Latest After Hours Trades. Select time range to see more EDMONTON, Alberta, June 29, 2023--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) ("Aurinia" or the "Company") today announced that its Board of Directors has initiated an exploration ...